TR201007107A1 - Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. - Google Patents
Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.Info
- Publication number
- TR201007107A1 TR201007107A1 TR2010/07107A TR201007107A TR201007107A1 TR 201007107 A1 TR201007107 A1 TR 201007107A1 TR 2010/07107 A TR2010/07107 A TR 2010/07107A TR 201007107 A TR201007107 A TR 201007107A TR 201007107 A1 TR201007107 A1 TR 201007107A1
- Authority
- TR
- Turkey
- Prior art keywords
- formulations
- regulating agent
- cefpodoxime proxetil
- containing taste
- taste regulating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, sefpodoksim proksetil içeren farmasötik formülasyonlara ilişkindir.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/07107A TR201007107A1 (tr) | 2010-08-25 | 2010-08-25 | Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. |
| EP11767093.5A EP2663289A2 (en) | 2010-08-25 | 2011-08-24 | Cefpodoxime proxetil formulations comprising taste regulating agent |
| PCT/TR2011/000201 WO2012026908A2 (en) | 2010-08-25 | 2011-08-24 | Cefpodoxime proxetil formulations comprising taste regulating agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/07107A TR201007107A1 (tr) | 2010-08-25 | 2010-08-25 | Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201007107A1 true TR201007107A1 (tr) | 2012-03-21 |
Family
ID=44764206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/07107A TR201007107A1 (tr) | 2010-08-25 | 2010-08-25 | Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2663289A2 (tr) |
| TR (1) | TR201007107A1 (tr) |
| WO (1) | WO2012026908A2 (tr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486425A (en) | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
| ES2248521T3 (es) * | 2001-02-27 | 2006-03-16 | Ranbaxy Laboratories, Ltd. | Composicion farmaceutica oral de cefpodoxima proxetilo. |
| TW200404550A (en) * | 2002-07-08 | 2004-04-01 | Sankyo Co | Cepharospolin formulation for oral use |
| KR20050062514A (ko) * | 2002-07-16 | 2005-06-23 | 랜박시 래보러터리스 리미티드 | 경구 투여용 분산성 정제 |
| WO2007017895A2 (en) * | 2005-05-05 | 2007-02-15 | Lupin Limited | Stabilized oral pharmaceutical compositions of cephalosporins |
| TR201002878A2 (tr) * | 2010-04-13 | 2011-10-21 | Bi̇lgi̇ç Mahmut | Sefpodoksim proksetil içeren farmasötik bileşimler. |
-
2010
- 2010-08-25 TR TR2010/07107A patent/TR201007107A1/tr unknown
-
2011
- 2011-08-24 EP EP11767093.5A patent/EP2663289A2/en not_active Withdrawn
- 2011-08-24 WO PCT/TR2011/000201 patent/WO2012026908A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2663289A2 (en) | 2013-11-20 |
| WO2012026908A3 (en) | 2012-09-07 |
| WO2012026908A2 (en) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180103A1 (ar) | مركب صيدلاني | |
| MD20150091A2 (ro) | Compuşi antivirali | |
| MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
| UA108101C2 (xx) | Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів | |
| IN2015DN03029A (tr) | ||
| GEP20156318B (en) | Heteroaryl derivatives as alpha7 nachr modulators | |
| EA201270256A1 (ru) | Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида | |
| PH12013501481A1 (en) | Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease | |
| MX344846B (es) | Combinacion de granulos cargados activos con activos adicionales. | |
| MX340147B (es) | Composiciones farmacéuticas y nutracéuticas del ácido abscísico. | |
| EA201500821A1 (ru) | Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов | |
| WO2014086453A8 (en) | Azaheterobicyclic compounds | |
| GB201113880D0 (en) | Novel compositions | |
| IN2015DN02645A (tr) | ||
| TR201007106A1 (tr) | Sefpodoksim proksetil formülasyonları. | |
| BR112013000941A2 (pt) | formulações de 14-epi-análogos de vitamina d | |
| TR201002878A2 (tr) | Sefpodoksim proksetil içeren farmasötik bileşimler. | |
| TR201009168A2 (tr) | Suda dağılan sefpodoksim proksetil formülasyonları. | |
| IN2015DN02643A (tr) | ||
| TR201007107A1 (tr) | Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. | |
| IN2015DN02646A (tr) | ||
| TR201010859A2 (tr) | Sefdinir içeren tablet formları. | |
| EA201101703A1 (ru) | 17β-АЛКИЛ-17α-ОКСИЭСТРАТРИЕНЫ | |
| IN2015DN02647A (tr) | ||
| IN2014KN02584A (tr) |